Troglitazone (Rezulin) and hepatic injury
- 1 October 2001
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 10 (6), 537-547
- https://doi.org/10.1002/pds.652
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Troglitazone and Liver Function AbnormalitiesDrug Safety, 2001
- Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes MellitusNew England Journal of Medicine, 1998
- PPAR-γ Gene Expression Is Elevated in Skeletal Muscle of Obese and Type II Diabetic SubjectsDiabetes, 1997
- TroglitazoneDrugs, 1997
- Thiazolidinediones in the Treatment of Insulin Resistance and Type II DiabetesDiabetes, 1996
- Switching Patterns of Non-Steroidal Anti-Inflammatory DrugsJournal of Pharmacoepidemiology, 1996
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)Journal of Biological Chemistry, 1995
- Insulin Action, Diabetogenes, and the Cause of Type II DiabetesDiabetes, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- The Importance of Adverse Reaction Reporting by PhysiciansPublished by American Medical Association (AMA) ,1988